Overview
Multiple non-ossifying fibromatosis, also known as multiple non-ossifying fibromas or Jaffe-Campanacci syndrome, is a rare skeletal disorder characterized by the presence of multiple non-ossifying fibromas (fibrous cortical defects) in the long bones. Non-ossifying fibromas are benign fibrous lesions that occur in the metaphyseal regions of bones, most commonly in the lower extremities (femur and tibia), though they can also affect the upper extremities. While solitary non-ossifying fibromas are relatively common incidental findings in children and adolescents, the occurrence of multiple lesions is rare and may be associated with extraskeletal manifestations. In Jaffe-Campanacci syndrome, multiple non-ossifying fibromas are accompanied by café-au-lait skin spots, intellectual disability in some cases, hypogonadism or cryptorchidism, ocular anomalies, and cardiovascular malformations. The skeletal lesions may weaken the bone cortex, predisposing affected individuals to pathological fractures. The condition typically presents during childhood or adolescence when the lesions are discovered incidentally on radiographs or following a pathological fracture. Treatment is primarily symptomatic and supportive. Small, asymptomatic non-ossifying fibromas generally require only observation, as many resolve spontaneously with skeletal maturation. Larger lesions that cause pain, threaten structural integrity, or result in pathological fractures may require surgical curettage and bone grafting. Regular orthopedic monitoring is recommended to assess lesion progression. The extraskeletal features, when present, are managed by appropriate specialists. The relationship between this condition and neurofibromatosis type 1 (NF1) has been debated, as some patients with multiple non-ossifying fibromas and café-au-lait spots may ultimately meet diagnostic criteria for NF1.
Also known as:
Variable
Can be inherited in different ways depending on the underlying gene
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
No FDA-approved treatments are currently listed for Multiple non-ossifying fibromatosis.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Multiple non-ossifying fibromatosis at this time.
New trials open frequently. Follow this disease to get notified.
Rare Disease Specialist
Rare Disease Specialist
Rare Disease Specialist
Rare Disease Specialist
Rare Disease Specialist
Rare Disease Specialist
Rare Disease Specialist
Rare Disease Specialist
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Multiple non-ossifying fibromatosis.
Community
No community posts yet. Be the first to share your experience with Multiple non-ossifying fibromatosis.
Start the conversation →Latest news about Multiple non-ossifying fibromatosis
No recent news articles for Multiple non-ossifying fibromatosis.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Multiple non-ossifying fibromatosis
What is Multiple non-ossifying fibromatosis?
Multiple non-ossifying fibromatosis, also known as multiple non-ossifying fibromas or Jaffe-Campanacci syndrome, is a rare skeletal disorder characterized by the presence of multiple non-ossifying fibromas (fibrous cortical defects) in the long bones. Non-ossifying fibromas are benign fibrous lesions that occur in the metaphyseal regions of bones, most commonly in the lower extremities (femur and tibia), though they can also affect the upper extremities. While solitary non-ossifying fibromas are relatively common incidental findings in children and adolescents, the occurrence of multiple lesio
At what age does Multiple non-ossifying fibromatosis typically begin?
Typical onset of Multiple non-ossifying fibromatosis is childhood. Age of onset can vary across affected individuals.
Which specialists treat Multiple non-ossifying fibromatosis?
20 specialists and care centers treating Multiple non-ossifying fibromatosis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.